DR-STEMI: Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI

Sponsor
University Hospital of Patras (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05605288
Collaborator
(none)
578
2
2
8
289
36.3

Study Details

Study Description

Brief Summary

Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed for undertaking percutaneous coronary angiography and interventions. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Coronary angiography +/- percutaneous coronary intervention
N/A

Detailed Description

Gaining vascular access is the first, mandatory step for undertaking percutaneous coronary angiography and interventions. The recent guidelines, published by European Society of Cardiology (ESC), American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), propose TRA as the gold standard for acute coronary syndromes (ACS), chronic coronary syndrome (CCS) percutaneous coronary interventions (PCI). Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Mutual point of all the previous RCTs is that excluded patients suffering from ST-elevation Myocardial Infraction (STEMI). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
578 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With ST-elevation Myocardial Infraction (STEMI): The DR-STEMI Trial
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Distal transradial artery access

Vascular access after cannulation of distal transradial artery through anatomical snuffbox for coronary angiography and interventions

Procedure: Coronary angiography +/- percutaneous coronary intervention
Coronary angiography +/- percutaneous coronary intervention

Active Comparator: Conventional transradial artery access

Vascular access after puncturing on the conventional transradial artery for performing coronary angiography and interventions

Procedure: Coronary angiography +/- percutaneous coronary intervention
Coronary angiography +/- percutaneous coronary intervention

Outcome Measures

Primary Outcome Measures

  1. Needle-to-balloon time [Immediately post-procedurally]

    Needle-to-balloon time

Secondary Outcome Measures

  1. Radial artery occlusion using Doppler examination prior to hospital discharge [The evaluation will be performed during hospitalization for STEMI and prior discharge, typically the 4th day after PCI]

    Radial artery patency evaluation with Doppler ultrasound prior to hospital discharge for detecting possible occlusion after cannulation

  2. Access site crossover rate [Immediately post-procedurally]

    Crossover rate from distal transradial artery access to other access point

  3. Sheath insertion time [Immediately post-procedurally]

    Duration required from the beginning of puncture until sheath insertion

  4. Total procedure time [Immediately post-procedurally]

    Total duration of coronary angiography and angioplasty

  5. The time interval between the initiation of radial artery puncture and the completion of coronary angiography, until the beginning of the possible PCI [Immediately post-procedurally]

    The time interval between the initiation of radial artery puncture and the completion of coronary angiography, until the beginning of the possible PCI

  6. Required time for coronary angiography completion, after sheath insertion [Immediately post-procedurally]

    Required time for coronary angiography completion, after sheath insertion

  7. Required time percutaneous coronary intervention completion [Immediately post-procedurally]

    Required time percutaneous coronary intervention completion

  8. Total fluoroscopy time [Immediately post-procedurally]

    Total fluoroscopy time

  9. Total Dose Area Product (DAP) [Immediately post-procedurally]

    Total Dose Area Product (DAP)

  10. Air Kerma [Immediately post-procedurally]

    Air Kerma

  11. Hemostasis time [3 hours]

    Time required for achieving hemostasis

  12. Vascular complications [24 hours]

    Vascular complications

  13. Hematomas classification (modified EASY classification) [24 hours]

    Hematomas classification using modified EASY which is compatible with dTRA

  14. 30-days Clinical follow-up (on site or via telephone call) [30 days]

    30-days Clinical follow-up (on site or via telephone call)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years old

  • Indication: ST-Elevation Myocardial Infraction

Exclusion Criteria:
  • Non-palpable radial artery

  • Previous CABG

  • Anatomical restrictions for forearm approach

  • Hemodynamic instability

  • Previous radial artery catheterization from the same arm during the last 30-days

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Cardiology, Centre Hospitalier Universitaire de Charleroi Charleroi Belgium
2 University Hospital of Patras Patras Greece 26500

Sponsors and Collaborators

  • University Hospital of Patras

Investigators

  • Principal Investigator: Grigorios Tsigkas, MD, PhD, University Hospital of Patras
  • Principal Investigator: Adel Aminian, MD, PhD, Centre Hospitalier Universitaire de Charleroi

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Grigorios Tsigkas, Assistant Professor of Cardiology, University Hospital of Patras
ClinicalTrials.gov Identifier:
NCT05605288
Other Study ID Numbers:
  • 26150/30.09.22
First Posted:
Nov 4, 2022
Last Update Posted:
Nov 10, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Grigorios Tsigkas, Assistant Professor of Cardiology, University Hospital of Patras
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2022